Form D · Private Equity Fund

BioIntel Venture Fund, L.P.

Seattle, WA · CIK 0002031377

Offering snapshot reported Aug 12, 2025 · SEC filing

Reported sold
$111M
Indefinite offering
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 12, 2025Amendment$110,900,000No comparisonNot reportedSEC filing
Aug 12, 2024InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-521239

Source: Form D, filed Aug 12, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

BIOINTEL VENTURE FUND, L.P.

Investment adviser: BIOINTEL VENTURE MANAGEMENT, L.P.

Gross asset value
$152M
Beneficial owners
36
ADV minimum commitment
$10M

Reported in Form ADV on Mar 24, 2026. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator STANDISH MANAGEMENT, LLC SEATTLE, Washington, United States Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor FRANK, RIMERMAN & CO. LLP PALO ALTO, California, United States
Custodian UBS AG NEW YORK, New York, United States Related to adviser: No
Provider details
Annual audit
Yes
Prime brokers
No
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

FRANK, RIMERMAN & CO. LLP
PCAOB 1596

UBS AG
LEI BFM8T61CT2L1QCEMIK50

Filing source

Form ADV 2063281 · Mar 24, 2026 · Schedule D 7.B.(1), fund 805-9729515317

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
N/A Bio Intel Venture Partners Gp, Llc Director
N/A Bio Intel Venture Partners, L.P. Director
Boris Nikolic Executive

Issuer details

Industry: Pooled Investment Fund (See others in industry)

Address:
814 East Highland Drive
Seattle, WA, 98102